"A global collaboration to stop the epidemic" urges Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, in an article in Horizon Magazine.Read more
The EU invests €30 million to map
new territory in health research
Brussels, 3 October 2011
BBC Radio 4 report on BLUEPRINT (4 minutes)
The EU has invested €30 million to understand the epigenome - a link between genes, environment and health. BLUEPRINT, a new large-scale research project, will lead to targeted diagnostics, new treatments and preventive measures for specific diseases in individual patients; an approach known as 'personalised medicine'. BLUEPRINT, officially launched on 1 October, is the European cornerstone of an international research cooperation effort – the International Human Epigenome Consortium (IHEC), bringing together organisations and researchers from across the globe. The project upholds the EU's pledge to maximise open access to results of publicly-funded research, as teams from around the world will have a platform to openly share their results.
Address: Milnwood, 13 North Parade, Horsham, West Sussex, RH12 2BT, UK
Tel/Fax: 0044 (0)1403 276363